A well-recognized long-term complication after Fontan procedure (FP), a complex cardiac surgery performed in patients with univentricular hearts, is the development of chronic liver disease and hepatocellular carcinoma (HCC). Due to the risk of cardiac and liver decompensation, liver resection of HCC is challenging and the laparoscopic approach has never been reported.
Introduction
Hepatocellular carcinoma (HCC) associated with chronic liver disease (CLD) is an increasing recognized complication after Fontan procedure (FP) due to long-term complex hemodynamic changes [1] . The FP is a palliative cardiac surgery used to divert the systemic and pulmonary vascular circulation in children with single ventricle physiology, whose survival dramatically increased over 80% after 20 years [1] . In the Fontan circulation, the systemic venous return is sent to the pulmonary arteries bypassing the right ventricle, with consequent chronic venous congestion causing CLD [1] . HCC might occur late after FP (>10 years) and is associated with high mortality [2] . Surgery represents the only curative treatment for HCC > 3 cm, however hepatic resections are challenging after FP for complex cardiac circulation and the CLD background, thus combined liverheart transplantation often remains the only therapeutic option [3] .
Despite the known benefits of laparoscopic liver resection (LLR) in CLD [4] , the laparoscopic approach has never been reported after FP. The limitations of LLR in Fontan-associated liver disease are related firstly to the adverse effects of pneumoperitoneum on the Fontan circulation due to increasing intra-abdominal and intrathoracic pressure, rising of pulmonary and systemic resistance, and reduction of the cardiac preload and output, which could be fatal [5] ; secondly, a severe portal hypertension may cause high-risk of bleeding during liver resection [3] . To the best of our knowledge, we report the first case of LLR for HCC after FP. The work has been reported in line with the SCARE criteria [6] .
Case presentation
A 33-year-old female, who had undergone FP as palliation for a single ventricle anomaly at 6 years of age ( Fig. 1) , presented alphafetoprotein (AFP) of 3005 ng/mL. Computer Tomography (CT) showed features of CLD associated with a 3.4 x 4.5 cm solid hepatic lesion in segment V (Fig. 2) . Considering the compensated cardiocirculatory condition (normal systolic heart function, no arrhythmias, good functional capacity) and the CLD grading (Model for EndStage Liver Disease score: 9, Child-Turcotte-Pugh stage: A) a LLR was planned.
Surgical procedure
The patient was placed in supine position, with her legs apart to apply the French position and the surgeon stood between the Surgery was performed by the insertion of four trocars: one sovraumbelical for the camera (11 mm), one working trocar in right lateral flank (11 mm), one working trocar in left pararectal position (12 mm) (from which the laparoscopic ultrasound probe was inserted) and one auxiliary trocar in the epigastric region (5 mm). The auxiliary epigastric trocar was inserted to use the aspirator during the liver resection, due to the high risk of bleeding from the cirrhotic liver, and to facilitate the laparoscopic cholecystectomy by holding the fundus of the gallbladder as for standard manner (the cholecystectomy was required due to its close proximity to the hepatic tumor).
patient's legs. Four trocars (two 11 mm, one 12 mm, one 5 mm) were placed into the abdomen as shown in Fig. 3 . After achieving a predetermined pressure of 10 mmHg, a 30-degree endoscope was inserted and a cirrhotic liver with small amount of ascites was visualized. The intraoperative ultrasound of the liver confirmed a 4 x 4.5 cm lesion of segment V near by the gallbladder and multiple regenerative nodules not suspicious of malignancy. Due to the close proximity of the lesion to the gallbladder, a conventional laparoscopic cholecystectomy was carried out.
With the assist of intraoperative ultrasound, an inner line was made on the liver surface with diathermy to mark the periphery of the tumor. Then, a radiofrequency ablation (RFA) with single needle probe was performed along the free-tumor margin of the hepatic lesion (2 cm outside -away from-the inner line of the tumor) in order to reduce the cut surface bleeding. The next step was an non-anatomical wedge resection of segment V. The parenchymal transection was performed without Pringle manoeuvre, by applying the harmonic scalper and the Cavitron Ultrasonic Surgical Aspirator (CUSA). Vessel structures were clipped by locked clips and then cut. The resected lesion and the gallbladder were extracted by endobag trough the supraomeblical trocar incision. The pneumoperitoneum was maintained at 8-10 mmHg through out the entire procedure and intraoperative blood losses were 100 mL.
During surgery, the anaesthetic management consisted of sevuforane/fentanyl and invasive central venous/arterial pressures monitoring to maintain a stable cardiac function and oxygenation, which were achieved by infusion of intravenous fluids (11 ml/Kg/h) and dopamine (3 mcg/Kg/min). A stable cardiac function was maintained during all intra-and peri-operative phases.
Histological findings
A well-differentiated HCC with trabecular growth pattern (Edmondson grade I; absence of vascular infiltration) of 4.5 × 4 x 4 cm (volume: 72 cm 3 ). No malignant cells were found in surgical margins of 1 cm (R0 resection). For immunohistochemistry, the HCC showed positive glypican, while negative pattern for beta-catenine, glutamine synthetase and loss of expression of liver fatty acid binding protein.
Post-operative course
Post-operative course was uneventful, characterized by stable liver and cardiac function; after 7 days the patient was discharged. After 3 months, AFP level was 30.14 ng/mL with negative CT. At 7 months from surgery HCC recurrence was detected and Sorafenib treatment combined with transarterial radioembolization was performed as downstage for combined heart-liver transplantation.
Discussion
In Fontan-associated CLD the management of HCC isn't defined yet due to its complexity and rarity [3] . The few cases reported in literature (n = 18) don't allow drawing guidelines yet. The current treatment options for HCC in Fontan patients with CLD include: open liver resection, associated with high risks of bleeding and post-operative liver-decompensation (including coagulopathy and ascites) causing severe cardiac dysfunction; chemoembolization or radiofrequency ablation, which frequently aren't feasible due to the presence of cardiac pacemakers, extrahepatic shunts and risk of thromboembolism; therefore combined liver-heart transplantation is often the only curative alternative [3] .
This case suggests that LLR in FP patients has lower risk of blood loss and liver decompensation, as demonstrated in patients with cirrhotic liver from other diseases [4] . The laparoscopic approach might represent a feasible treatment in patients with Fontan physiology by 1) minimizing the pneumoperitoneum insufflation to ensure low intra-abdominal/intra-thoracic pressures and satisfactory ventilation, with low pulmonary/systemic resistance; 2) adequate intravascular volume administration to maintain good cardiac output; 3) avoiding surgical techniques that reduce the cardiac preload (Pringle manoeuvre and blood losses during parenchymal transection).
The liver resection assisted by RFA is a useful tool in Fontan patients with cirrhotic liver since RFA provides an avascular liver resection plan, minimizing blood loss and the need of hepatic inflow obstruction (Pringle manoeuvre). Moreover, the RFA along the cut surface is effective in parenchymal sparing and in achieving complete tumor resection (R0) as demonstrated in other series [7] .
Conclusion
LLR for HCC in FP patients is safe and feasible thus it needs an adequate pre-operative assessment of the cardiac function and the CLD severity. In FP patients, the LLR might be considered as an alternative approach offering potential short-(decreased cardiac-liver decompensation, early recovery) and long-term (reduced visceral adhesions) benefits, either as definitive or bridge treatment before transplantation.
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